Zomedica Pharmaceuticals Corp Long-term Investment Intensity
Zomedica Pharmaceuticals Corp long-term investment intensity. Zomedica Pharmaceuticals Corp (ZOM) has a Long-term Investment Intensity of 0.5% as of September 2024. Long-term investments of $966.00K represent 0.5% of total assets of $214.12 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Zomedica Pharmaceuticals Corp current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Zomedica Pharmaceuticals Corp (2022–2023)
Long-term investment intensity of Zomedica Pharmaceuticals Corp from 2022 to 2023. This chart shows how Zomedica Pharmaceuticals Corp's Long-term Investment Intensity has evolved across 2 annual periods from 2022 to 2023. As of September 2024, the intensity stands at 0.5%, reflecting long-term investments of $966.00K against total assets of $214.12 Million USD. See Zomedica Pharmaceuticals Corp defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Zomedica Pharmaceuticals Corp Long-term Investment Intensity by Year (2022–2023)
Zomedica Pharmaceuticals Corp long-term investment intensity by year from 2022 to 2023. The table below presents the year-by-year Long-term Investment Intensity for Zomedica Pharmaceuticals Corp from 2022 to 2023, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Zomedica Pharmaceuticals Corp balance sheet assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 4.0% | $10.01 Million | $253.20 Million | ▼ -10.6 pp |
| 2022 | 14.6% | $40.71 Million | $279.61 Million | — |